Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G/A for KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV).
- Disclosed ownership: 3.7%.
- Date of event: 31 Mar 2026.
MILLENNIUM MANAGEMENT LLC - 31 Mar 2026 SCHEDULE 13G/A Report for KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- KALV
- Shares outstanding
- 51,679,622 shares
- Disclosed Ownership
- 1,912,146 shares
- Ownership
- 3.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 01 May 2026, 17:32:24 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 30 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 3.7% ownership in KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 30 Dec 2025.
- Current filing was accepted on 01 May 2026, 17:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 3% | 1,546,105 | 0 | 1,546,105 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 3.7% | 1,912,146 | 0 | 1,912,146 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 3.7% | 1,912,146 | 0 | 1,912,146 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 3.7% | 1,912,146 | 0 | 1,912,146 | /s/ Israel A. Englander | Israel A. Englander |